Related Experiment Videos
Platelets and cancer: implications for antiangiogenic therapy
Mohit Trikha1, Marian T Nakada
1Department of Oncology Research, Centocor, Malvern, Pennsylvania 19355, USA. trikham@centocor.com
Seminars in Thrombosis and Hemostasis
|March 9, 2002
Summary
Platelets are key players in cancer progression, contributing to metastasis and tumor growth by releasing angiogenic factors. Understanding platelet interactions with tumors is crucial for cancer treatment strategies.
Area of Science:
- Oncology
- Hematology
- Cancer Biology
Background:
- Thromboembolism is a leading cause of death in cancer patients.
- Cancer-associated thrombotic complications include disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, and thrombocytosis.
- Tumor cells interact extensively with the hemostatic system, particularly platelets.
Purpose of the Study:
- To review the literature on the role of platelets in tumor growth.
- To explore platelet contributions to angiogenesis and metastasis in cancer.
Main Methods:
- Literature review of recent studies on platelet-cancer interactions.
- Analysis of platelet functions in the context of tumor progression.
Main Results:
- Platelets promote tumor progression through metastasis, immune evasion, invasion, and angiogenesis.
- Platelets release angiogenic factors like vascular endothelial growth factor (VEGF) and thrombin, stimulating tumor growth.
- Leaky tumor vasculature facilitates platelet interaction with tumor cells.
Conclusions:
- Platelets significantly contribute to cancer progression, angiogenesis, and metastasis.
- Targeting platelet-tumor interactions may offer novel therapeutic strategies for cancer.